2016
DOI: 10.1161/circinterventions.116.003886
|View full text |Cite
|
Sign up to set email alerts
|

Early Endocarditis and Delayed Left Ventricular Pseudoaneurysm Complicating a Transapical Transcatheter Mitral Valve-in-Valve Implantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
14
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(14 citation statements)
references
References 4 publications
0
14
0
Order By: Relevance
“…From 2009 to March 31, 2018, 66 published reports describing 172 patients undergoing TMVIV implantation for degenerated mitral bioprostheses and 35 articles describing 73 patients undergoing TMVIR implantation for failed annuloplasty rings were identified (Figure ). The patients were diagnosed with MR, MS, or mixed lesions according to the articles but the failure modes of 34 patients were unknown.…”
Section: Resultsmentioning
confidence: 99%
“…From 2009 to March 31, 2018, 66 published reports describing 172 patients undergoing TMVIV implantation for degenerated mitral bioprostheses and 35 articles describing 73 patients undergoing TMVIR implantation for failed annuloplasty rings were identified (Figure ). The patients were diagnosed with MR, MS, or mixed lesions according to the articles but the failure modes of 34 patients were unknown.…”
Section: Resultsmentioning
confidence: 99%
“…2) Recently, the "offlabel" use of a variety of Amplatzer occluders has enabled the transcatheter therapy of a handful of high-risk surgical patients with ventricular PSAs. [3][4][5][6][7][8] However, the experience of transcatheter closure of ventricular PSA is limited, due to the rarity of its occurrence. Thus far, very limited data exists regarding the patient selection of transcatheter closure of ventricular PSAs.…”
Section: Discussionmentioning
confidence: 99%
“…1) It is a rare, yet life-threatening complication that may occur following acute myocardial infarction (AMI), cardiac surgery, trauma, or transcatheter valve replacement. [2][3][4][5][6] If left untreated, ventricular PSA carries a 30-45% risk of rupture within the first year, significantly increasing the risk of sudden cardiac death. Thus, aggressive treatment is recommended in all cases regardless of whether the patient is symptomatic.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…(62). Patients with a LVPA with an increased size despite regular conservative treatment warrant interventional management (37). Some authors proposed that due to the high propensity of LVPA rupture, patients with a LVPA are indicated for a cardiac surgery upon diagnosis is made (63).…”
Section: Treatmentmentioning
confidence: 99%